Alamar Biosciences(NASDAQ) ALMR

Market Cap$1.97B

Since IPO (2026)+29%

5 YearN/A

1 YearN/A

1 Month+12%

$28.51

+1.46%

+0.41Today

After hours$28.42-$0.09 (-0.32%)

Alamar Biosciences last closing stock price
Metric	Price	Date
Last close	USD 28.46	2026-08-07

Alamar Biosciences stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+12.22%	USD 25.36	2026-07-31
1 month	+12.49%	USD 25.30	2026-07-08
3 month	+18.78%	USD 23.96	2026-05-08
Since inception	+29.36%	USD 22.00	2026-04-17

Alamar Biosciences Financials at a Glance

Market Cap

$1.97B

Revenue (TTM)

$39.13

Net Income (TTM)

-$28.98

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

1.49 (Average)

Dividend

$0.00

Beta (Volatility)

1.49 (Average)

Price

$28.51

Volume

135,268.776

Open

$28.40

Price

$28.51

Volume

135,268.776

Open

$28.40

Previous Close

$28.46

Daily Range

$27.94 - $28.99

52-Week Range

$17.00 - $29.43

Estimated Earnings Date

Aug 10, 2026

Dividend

$0.00

Beta (Volatility)

1.49 (Average)

Price

$28.51

Volume

135,268.776

Open

$28.40

Previous Close

$28.46

Daily Range

$27.94 - $28.99

52-Week Range

$17.00 - $29.43

Estimated Earnings Date

Aug 10, 2026

ALMR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Alamar Biosciences

Alamar Biosciences, Inc. operates as a commercial-stage proteomics firm, specializing in the highly sensitive identification of various proteins for scientific research and medical applications. The company offers an integrated platform that combines proprietary instruments, specialized consumables, and unique software for accurate protein quantification.

Products and Services

Proprietary instruments for protein analysis
Specialized consumables tailored for proteomics
Unique software for data management and analysis

Growth Outlook

Recent revenue of $26.04 million indicates strong market demand
Current ratio of 3.99 suggests robust liquidity position
Significant cash reserves of $64.59 million support future growth initiatives

Financial Highlights

Net income for Q1 2026 was -$21.33 million
Gross profit margin of 55.53% reflects operational efficiency
Operating expenses totaled $26.80 million, indicating investment in growth

Alamar Biosciences is positioned in the biotechnology sector, focusing on innovative solutions for protein analysis. The company's recent revenue performance highlights its potential in a growing market, while a strong liquidity position ensures it can navigate future challenges. Despite reporting a net loss, the gross profit margin indicates effective cost management, and ongoing investments in research and development may lead to future profitability. The combination of proprietary technology and a solid financial foundation makes Alamar Biosciences an intriguing option for investors interested in the biotechnology field.

AI Generated • Jul 21, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

250

CEO

Yu Ling Luo, PhD

Website

www.alamarbio.com

Headquarters

Fremont, CA 94538, US

ALMR Financials

Key Financial Metrics (TTM)

Gross Margin

56.20%

Operating Margin

-42.22%

Net Income Margin

-40.18%

Return on Equity

18.76%

Return on Capital

N/A

Return on Assets

-21.30%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.97B

Shares Outstanding

69.31M

Volume

135.27K

Avg. Volume

284.05K

Financials (TTM)

Gross Profit

$14.46M

Operating Income

-$12.35M

EBITDA

-$19.47M

Operating Cash Flow

-$20.35M

Capital Expenditure

-$600.00K

Free Cash Flow

-$20.95M

Cash & ST Invst.

$64.59M

Total Debt

$340.55M

Alamar Biosciences Performance Analysis

Alamar Biosciences annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2024	2024-12-31	USD 25,142,000	N/A
2025	2025-12-31	USD 74,211,000	195.2%

Alamar Biosciences sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q1	2026-03-31	N/A

Alamar Biosciences annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2024	2024-12-31	USD -0.71	N/A
2025	2025-12-31	USD -0.45	-36.6%

Alamar Biosciences sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q1	2026-03-31	N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$26.04M

N/A

Gross Profit

$14.46M

N/A

Gross Margin

55.53%

N/A

Market Cap

$1.97B

N/A

Market Cap/Employee

$8.89M

N/A

Employees

222

N/A

Net Income

-$21.33M

N/A

EBITDA

-$19.47M

N/A

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$64.59M

N/A

Total Debt

$340.55M

N/A

Accounts Receivable

$19.52M

N/A

Inventory

$39.93M

N/A

Long Term Debt

$338.95M

N/A

Short Term Debt

$1.60M

N/A

Return on Assets

-21.30%

N/A

Return on Invested Capital

-26.95%

N/A

Free Cash Flow

-$20.95M

N/A

Operating Cash Flow

-$20.35M

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,757.64+0.01%

^DJIDJI

^DJIDJI$54,036.93+0.00%

^IXICNASDAQ

^IXICNASDAQ$26,690.62+0.01%

BTCBitcoin

BTCBitcoin$64,991.00+0.00%

SPCXSPCX

SPCXSPCX$133.11+0.16%

AAPLAAPL

AAPLAAPL$313.33+0.00%

AMZNAMZN

AMZNAMZN$274.48+0.01%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$133.11+0.16%

TTDThe Trade Desk

TTDThe Trade Desk$13.80-0.22%

NVDANvidia

NVDANvidia$223.96+0.02%

TLTiShares Trust - iShares 20+ Year Treasury Bond ETF

TLTiShares Trust - iShares 20+ Year Treasury Bond ETF$82.76+0.00%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$8.11+0.06%

PLTRPalantir Technologies

PLTRPalantir Technologies$172.01+0.10%

INTCIntel

INTCIntel$101.65+0.02%

Questions About ALMR

What is the current price of Alamar Biosciences?

Alamar Biosciences is trading at $28.46 per share.

What is the 52-week range for Alamar Biosciences?

Over the past 52 weeks, Alamar Biosciences has traded between $17.00 and $29.43.

How much debt does Alamar Biosciences have?

As of the most recent reporting period, Alamar Biosciences reported total debt of $340.55M.

How much cash does Alamar Biosciences have on hand?

Alamar Biosciences reported $64.59M in cash and cash equivalents in its most recent financial results.

What is Alamar Biosciences’s dividend yield?

Alamar Biosciences does not currently have a dividend yield.

Alamar Biosciences(NASDAQ) ALMR

Alamar Biosciences Financials at a Glance

ALMR News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Alamar Biosciences

ALMR Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Alamar Biosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ALMR

What is the current price of Alamar Biosciences?

What is the 52-week range for Alamar Biosciences?

How much debt does Alamar Biosciences have?

How much cash does Alamar Biosciences have on hand?

What is Alamar Biosciences’s dividend yield?

Premium Investing Services